سلول های بنیادی مزانشیمال مغز استخوان قادر به کاهش تغییرات آسماتیک ناشی از اوالبومین می باشد(2017)

احمدی, مهدی and رهبر قاضی, رضا and اصلانی, محمدرضا and شهبازفر, امیر علی and کاظمی, معصومه and کیهان منش, رعنا (1395) سلول های بنیادی مزانشیمال مغز استخوان قادر به کاهش تغییرات آسماتیک ناشی از اوالبومین می باشد(2017). Biomedicine & Pharmacotherapy ــ 85 (Januar). pp. 28-40. شاپا 0753-3322

[img] Text
محدود به Repository staff only


Official URL: http://www.sciencedirect.com/science/journal/07533...


Bone marrow mesenchymal stem cells and their conditioned media could potentially ameliorate ovalbumin-induced asthmatic changes

English Abstract

Background: The major feature of asthma is governed by chronic airway inflammation. This investigation was proposed to achieve the suitable candidate for ameliorating long-term chronic asthmatic changes of respiratory tract. Methods: 36 rats were classified into healthy (C) and ovalbumin (OVA)-sensitized animals (S). To sensitize, the rats were exposed to OVA over a course of 32 +1 days. One day after sensitization, equal six different groups were subjected to experimental procedure (n = 6); Rats only received intratracheally 50 ml PBS (CPT and SPT groups), 50 ml conditioned medium (CM) (CST and SST groups) and 50 ml PBS containing 2 * 106 rat bone marrow-derived mesenchymal stem cells (rBMMSCs) (CCT and SCT groups). Two weeks after treatment, tracheal responsiveness, immunologic responses and recruitment of rBMMSCs into the lung as well as pathological changes were evaluated. Results: A high degree of tracheal responsiveness, total white blood cell and percentages of eosinophil and neutrophil was significantly recorded in all sensitized groups rather than of controls (p < 0.001 to p < 0.05). Of interest, all above-mentioned parameters decreased significantly in SST and notably SCT groups as compared to S group (p < 0.001 to p < 0.05). The results revealed decrease number of blood CD3+CD4+ and concurrent increase in CD3+CD8+ in all sensitized rats as compared to control (p < 0.001 to p < 0.05). Noticeably, no significant modulatory effects of either cell or CM administration were achieved on the CD3+CD4+ and CD3+CD8+ populations in non-asthmatic rats. Moreover, the number of CD3+CD4+ in SST and SCT groups tended to increase, which coincided with a decreased manner of CD3+CD8+ populations as compared with S group (p < 0.001 to p < 0.05). However, the CD3+CD4+ cells in SCT rats were significantly higher than the group SST (p < 0.01) whereas CD3+CD8+ cells diminished simultaneously (p < 0.001). Real-time PCR analysis further showed that both CM and particularly MSCs changed the expression of interleukin (IL)-4 and IL-10 in the asthmatic groups to the near level of control rats (p<0.001 to p < 0.05). Histopathological analysis revealed a profound reduction of lungs injuries in asthmatic rats when received CM and peculiarly mesenchymal stem cells (p < 0.01 to p < 0.05). Conclusion: Our study shed light on the superior effects of rBMMSCs, rather than CM, in attenuating of chronic asthmatic changes in the rat model.

Item Type:Article
زبان سند : انگلیسی
نویسنده اول :مهدی احمدی
نویسنده :رضا رهبر قاضی
نویسنده :محمدرضا اصلانی
نویسنده :امیر علی شهبازفر
نویسنده :معصومه کاظمی
نویسنده مسئول :رعنا کیهان منش
Additional Information:IF:2.326 Indexed in: ISI, PubMed/Medline, Scopus, EMBASE
کلیدواژه ها (انگلیسی):Asthma, Inflammation, Mesenchymal stem cells, Conditioned medium, Intratracheally, Lymphocyte
Subjects:QT physiology
QU Biochemistry
WF Respiratory System
Divisions:Faculty of Medicine > Department of Basic Sciences > Department of physiology
ID Code:8824
Deposited By: Dr Mohammad Reza Aslani
Deposited On:17 Mar 1396 06:53
Last Modified:26 Jun 1402 13:27

Repository Staff Only: item control page

Document Downloads

More statistics for this item...